Drug intelligence / Profile preview

Spermfit

Development stage: Unknown
Lead developer: Switzer Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Spermfit is an oral tablet developed and manufactured by Switzer Life Science Pvt. Ltd., an Indian pharmaceutical company specializing in generic formulations. It is indicated to enhance the effectiveness of infertility treatments in males by supporting reproductive health. While the specific quantitative composition is not publicly disclosed, the product belongs to a category of nutraceuticals typically containing a blend of antioxidants, amino acids, and vitamins designed to optimize sperm parameters such as count and motility. Switzer Life Science operates a WHO GMP certified facility in Gujarat, India.

Brand names: Spermfit
Other names: Spermfit Tablet

Beyond the preview

Go deeper on Spermfit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spermfit.

Explore the full profile